Abstract
Mucormycosis (zygomycosis) is an uncommon infection that afflicts severely immunocompromised patients and those with poorly controlled diabetes mellitus. A recent increase in the incidence of mucormycosis at many transplant centres has been linked to the introduction and widespread use of voriconazole prophylaxis in these high-risk populations. However, it is not known if this association reflects a true epidemiological link or represents a marker of changing immunosuppression occurring in parallel with the evolution of transplant practices and immunosuppression strategies.
Original language | English (US) |
---|---|
Pages (from-to) | 93-97 |
Number of pages | 5 |
Journal | Clinical Microbiology and Infection |
Volume | 15 |
Issue number | SUPPL. 5 |
DOIs | |
State | Published - Oct 2009 |
Keywords
- Immunocompromised
- Invasive fungal infections
- Mucormycosis
- Posaconazole
- Voriconazole
- Zygomycosis